Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 12c; Offers Guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of $0.07, $0.12 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.17 billion versus the consensus estimate of $2.04 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2023 revenue of $8.45-8.65 billion, versus the consensus of $8.35 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• SuperCom (SPCB) Tops Q3 EPS by 43c